Other GI Motility and Neurogastroenterology Research Studies

Enrolling: Yes

Principle Investigator: John M. Wo, MD

Duration: 2 years

Primary Outcomes Measured: 

1. Follow up clinical data will be obtained before, 6 months, 1.5 years, and 2 years after the full thickness biopsy
2. Follow up data PAGI_SYM Overall Treatment Effect by Patient Overall Treatment Effect by Physician

Secondary Outcomes Measured:

1. Responders will be defined as >50% improvement of the GCSI total score at 6 month after surgical GES.
2. Patients with gastroparesis from type 1 DM versus patients with idiopathic gastroparesis.
3. Patients with gastroparesis from type 1 DM versus gastroparesis from type 2 DM.
4. Neuromuscular pathology results of the gastric body and proximal jejunum will be correlated with the following: Symptom severity (GCSI total score), predominant symptom presentation, severity of delayed gastric emptying.
   
   

Interested in this study? Please contact the coordinator below:
Kara Murphy
clarkara@iu.edu

Anita Gupta
anigupta@iu.edu

Enrolling: Yes

Principle Investigator: John M. Wo, MD

Duration: TBD

Primary Outcomes Measured:  Identification of patients by accurate motility diagnosis.

Secondary Outcomes Measured:

1. To develop Patient Reported Outcome (PRO) measurements in patients with small intestinal bacterial overgrowth (SIBO)
2. To develop Patient Reported Outcome (PRO) measurements in patients with gastroparesis
   
   

Enrolling: Yes

Principle Investigator: Akira Saito, MD

Duration: Recruiting 50 patients based in the US.

Primary Outcomes Measured:

1. Develop a de novo CIPO-specific PRO that is able to capture change in core CIPO visible signs and symptoms across all etiologies and severity levels.
2. Develop a de novo CIPO-specific PRO that is fit-for-purpose for use as a primary endpoint in a clinical trial setting.

Interested in this study? Please contact the coordinator below:
Kara Murphy
clarkara@iu.edu
(317) 278-0612